Patent ID: 8252904

Claim:
A monoclonal antibody that is capable of specifically binding to glycodelin, wherein the antibody is selected from the group consisting of: (a) the monoclonal antibody produced by the hybridoma cell line 2G7.1, deposited with the ATCC as Patent Deposit No. PTA-9684; (b) the monoclonal antibody produced by the hybridoma cell line 8G8.3, deposited with the ATCC as Patent Deposit No. PTA-9685; (c) the monoclonal antibody produced by the hybridoma cell line 3A10.25, deposited with the ATCC as Patent Deposit No. PTA-9686; (d) a monoclonal antibody that binds to an epitope capable of binding the monoclonal antibody produced by the hybridoma cell line 2G7.1, 8G8.3, or 3A10.25; (e) a monoclonal antibody that competitively interferes in a competitive binding assay with the monoclonal antibody produced by the hybridoma cell line 2G7.1, 8G8.3, or 3A10.25; and, (f) a monoclonal antibody that is an antigen binding fragment of a monoclonal antibody of (a)-(e), wherein the fragment retains the capability of specifically binding to glycodelin.